NCT02666001View on ClinicalTrials.gov

A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

January 12, 2016

Primary Completion Date

June 29, 2016

Study Completion Date

June 29, 2016

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-663068

BMS-663068

DRUG

Methadone

Methadone

DRUG

Buprenorphine and Norbuprenorphine

Buprenorphine and Norbuprenorphine

Trial Locations (2)

32809

GSK Investigational Site, Orlando

66211

GSK Investigational Site, Overland Park

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY